FR12C0064I1 - - Google Patents
Info
- Publication number
- FR12C0064I1 FR12C0064I1 FR12C0064C FR12C0064I1 FR 12C0064 I1 FR12C0064 I1 FR 12C0064I1 FR 12C0064 C FR12C0064 C FR 12C0064C FR 12C0064 I1 FR12C0064 I1 FR 12C0064I1
- Authority
- FR
- France
- Prior art keywords
- isoquinoline
- aminoethyl
- benzo
- dextran
- lactose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Injectable pharmaceutical compositions containing 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione dimaleate as active ingredient in the form of a lyophilised powder with a carrier selected from lactose and dextran, mixed with sodium chloride.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002MI001040A ITMI20021040A1 (en) | 2002-05-16 | 2002-05-16 | INJECTABLE PHARMACEUTICAL COMPOSITIONS OF AN ANTHROCENEDIONAL DERIVATIVE WITH ANTI-TUMOR ACTIVITY |
PCT/EP2003/004871 WO2003097101A1 (en) | 2002-05-16 | 2003-05-09 | Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
Publications (2)
Publication Number | Publication Date |
---|---|
FR12C0064I1 true FR12C0064I1 (en) | 2012-12-14 |
FR12C0064I2 FR12C0064I2 (en) | 2013-08-16 |
Family
ID=11449903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR12C0064C Active FR12C0064I2 (en) | 2002-05-16 | 2012-10-25 | INJECTABLE PHARMACEUTICAL COMPOSITIONS OF AN ANTHRACENEDIONE DERIVATIVE WITH ANTITUMOR ACTION |
Country Status (12)
Country | Link |
---|---|
US (3) | US20060199831A1 (en) |
EP (1) | EP1503797B1 (en) |
JP (1) | JP4624780B2 (en) |
AT (1) | ATE381944T1 (en) |
AU (1) | AU2003240613A1 (en) |
CA (1) | CA2486001C (en) |
DE (1) | DE60318310T2 (en) |
ES (1) | ES2298521T3 (en) |
FR (1) | FR12C0064I2 (en) |
IT (1) | ITMI20021040A1 (en) |
MX (1) | MXPA04011348A (en) |
WO (1) | WO2003097101A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2106788A1 (en) * | 2008-04-04 | 2009-10-07 | Ipsen Pharma | Liquid and freeze dried formulations |
CN105769776B (en) * | 2016-03-26 | 2018-05-11 | 青岛市肿瘤医院 | A kind of freeze-dried composition for treating non-Hodgkin lymphoma and preparation method thereof |
CN108186560A (en) * | 2016-03-26 | 2018-06-22 | 夏建明 | A kind of parenteral solution for treating non-Hodgkin lymphoma and preparation method thereof |
CN105997896B (en) * | 2016-05-28 | 2019-07-05 | 长沙秋点兵信息科技有限公司 | The injection freeze-dried powder and preparation method thereof for treating non-Hodgkin lymphoma |
CN106176630B (en) * | 2016-08-03 | 2019-01-04 | 湖北丽益医药科技有限公司 | A kind of preparation method of injection maleic acid Pixantrone aseptic powdery |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3590124A (en) * | 1967-06-27 | 1971-06-29 | Us Navy | Blood transfusion fluids having reduced turbulent friction properties |
JP2690009B2 (en) * | 1986-07-10 | 1997-12-10 | エーザイ 株式会社 | Cefalosporin injection |
IE920754A1 (en) | 1991-03-08 | 1992-09-09 | Univ Vermont | 6,9 BIS(SUBSTITUTED-AMINO) BENZO[g]-ISOQUINOLINE-5,10-DIONES |
JP3501471B2 (en) * | 1992-06-15 | 2004-03-02 | 旭化成ファーマ株式会社 | Stabilizing composition and method of calcitonin |
JPH08126685A (en) * | 1994-01-26 | 1996-05-21 | Shionogi & Co Ltd | Lyophilization of dextran compound |
US5587382A (en) * | 1994-03-28 | 1996-12-24 | Boehringer Mannheim Italia, Spa | 6,9-bis[(2-aminoethyl) amino]benzo [g]isoquinoline-5,10- dione dimaleate; an aza-anthracenedione with reduced cardiotoxicity |
CA2309321A1 (en) * | 1997-11-10 | 1999-05-20 | G.D. Searle & Co. | Use of alkylated iminosugars to treat multidrug resistance |
GB9808922D0 (en) * | 1998-04-24 | 1998-06-24 | Cantab Pharmaceuticals Res Ltd | Virus preparations |
TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
IT1315253B1 (en) * | 1999-10-22 | 2003-02-03 | Novuspharma Spa | LIPOSOMIAL PREPARATION OF 6,9-BIS- (2-AMINOXYL) AMINO | BENZOG | ISOCHINOLIN-5,10-DIONE DIMALEATO |
-
2002
- 2002-05-16 IT IT2002MI001040A patent/ITMI20021040A1/en unknown
-
2003
- 2003-05-09 AT AT03729997T patent/ATE381944T1/en not_active IP Right Cessation
- 2003-05-09 DE DE60318310T patent/DE60318310T2/en not_active Expired - Lifetime
- 2003-05-09 ES ES03729997T patent/ES2298521T3/en not_active Expired - Lifetime
- 2003-05-09 US US10/514,301 patent/US20060199831A1/en not_active Abandoned
- 2003-05-09 CA CA2486001A patent/CA2486001C/en not_active Expired - Lifetime
- 2003-05-09 MX MXPA04011348A patent/MXPA04011348A/en active IP Right Grant
- 2003-05-09 JP JP2004505097A patent/JP4624780B2/en not_active Expired - Lifetime
- 2003-05-09 WO PCT/EP2003/004871 patent/WO2003097101A1/en active IP Right Grant
- 2003-05-09 AU AU2003240613A patent/AU2003240613A1/en not_active Abandoned
- 2003-05-09 EP EP03729997A patent/EP1503797B1/en not_active Expired - Lifetime
-
2010
- 2010-12-10 US US12/964,861 patent/US9211262B2/en active Active
-
2012
- 2012-10-25 FR FR12C0064C patent/FR12C0064I2/en active Active
-
2015
- 2015-11-10 US US14/937,689 patent/US20160256557A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20160256557A1 (en) | 2016-09-08 |
ITMI20021040A0 (en) | 2002-05-16 |
US9211262B2 (en) | 2015-12-15 |
DE60318310T2 (en) | 2008-12-11 |
FR12C0064I2 (en) | 2013-08-16 |
EP1503797A1 (en) | 2005-02-09 |
CA2486001C (en) | 2010-04-13 |
ITMI20021040A1 (en) | 2003-11-17 |
JP4624780B2 (en) | 2011-02-02 |
ES2298521T3 (en) | 2008-05-16 |
EP1503797B1 (en) | 2007-12-26 |
ATE381944T1 (en) | 2008-01-15 |
CA2486001A1 (en) | 2003-11-27 |
JP2005530792A (en) | 2005-10-13 |
US20060199831A1 (en) | 2006-09-07 |
US20110144147A1 (en) | 2011-06-16 |
DE60318310D1 (en) | 2008-02-07 |
AU2003240613A1 (en) | 2003-12-02 |
MXPA04011348A (en) | 2005-08-15 |
WO2003097101A1 (en) | 2003-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1036970A1 (en) | Compounds and compositions for delivering active agents. | |
FR12C0064I1 (en) | ||
MY125516A (en) | Novel composition based on thiazolidinedione and metformin and use | |
MY125921A (en) | Compositions containing organic compounds | |
EP1015008A4 (en) | Compounds and compositions for delivering active agents | |
AU1453200A (en) | Cyclic peptide ligands that target urokinase plasminogen activator receptor, their pharmaceutical compositions and use | |
HK1036969A1 (en) | Compounds and compositions for delivering active agents | |
HK1065483A1 (en) | 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives | |
PT1299348E (en) | Compounds and compositions for delivering active agents | |
IL188774A0 (en) | Compositions for delivery of drug combinations | |
PT1083884E (en) | PROCESS FOR THE STABILIZATION OF POLYVINYL-PYRROLIDONE COMPOSITIONS | |
IL162141A0 (en) | Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemoterapy | |
HK1024177A1 (en) | Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles | |
MXPA03007857A (en) | Compounds and compositions for delivering active agents. | |
IT1302682B1 (en) | ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING BUPRENORPHINE | |
YU13301A (en) | Muscarinic agonists and antagonists | |
ZA200110150B (en) | Streptogramin derivatives, preparation and compositions containing them. | |
MXPA03005221A (en) | Pharmaceutical dronedarone composition for parenteral administration. | |
BG105570A (en) | Pharmaceutical compositions for modified release insulin sensitiser | |
PT1105102E (en) | PHARMACEUTICAL COMPOSITION INJECTABLE BASED ON A PHARMACEUTICALLY ACCEPTABLE SALT OF CLOPIDOGREL OR TICLOPIDINE | |
BG106151A (en) | Pharmaceutical complex | |
MXPA02012015A (en) | Ligands of integrin receptors. | |
ATE307579T1 (en) | COMPOSITIONS CONTAINING PECTIN AND ASCORBIC ACID | |
PL351376A1 (en) | Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines | |
MY143821A (en) | Biologically active peptide comprising tyrosyl-seryl-valine (ysv) |